INSOMNIA CHRONIC
Clinical trials for INSOMNIA CHRONIC explained in plain language.
Never miss a new study
Get alerted when new INSOMNIA CHRONIC trials appear
Sign up with your email to follow new studies for INSOMNIA CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smart lights and sounds could help seniors sleep better and think sharper
Symptom relief Not yet recruitingThis study tests a new way to treat insomnia in older adults using smart devices like lights and sounds, combined with a proven talk therapy (CBT-I). About 180 healthy adults aged 65 and older with sleep problems will use wearable trackers and a smartphone app. The goal is to see…
Matched conditions: INSOMNIA CHRONIC
Phase: PHASE2 • Sponsor: Proactive Life Inc • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
Sleep apnea sufferers: tackling insomnia first may boost CPAP success
Symptom relief Not yet recruitingThis study looks at 120 adults aged 45-65 who have both sleep apnea and chronic insomnia. Everyone gets a CPAP machine, but half also start a digital insomnia program right away. The goal is to see if early insomnia treatment helps people use CPAP more and improves their overall …
Matched conditions: INSOMNIA CHRONIC
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Symptom relief
Last updated May 11, 2026 20:46 UTC
-
New study tests sleep therapy for the grieving
Symptom relief Not yet recruitingThis study looks at whether a brief behavioral therapy for insomnia (BBTI) can improve sleep in people who have lost a loved one and now have trouble sleeping. About 58 adults who have been grieving for at least 6 months and have insomnia will take part. They will either receive …
Matched conditions: INSOMNIA CHRONIC
Phase: NA • Sponsor: University of Aarhus • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC
-
New sleep aid APSTZD put to the test in Mid-Stage trial
Symptom relief Not yet recruitingThis study tests a new insomnia drug, APSTZD, to see if it helps people stay asleep. About 222 adults with chronic insomnia will receive either APSTZD, an active comparator, or a placebo for 6 weeks. The main goal is to measure how much time they spend awake after falling asleep,…
Matched conditions: INSOMNIA CHRONIC
Phase: PHASE2 • Sponsor: Apsen Farmaceutica S.A. • Aim: Symptom relief
Last updated May 01, 2026 15:57 UTC